Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

@article{Tamura2008SerumAL,
  title={Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C},
  author={Yasushi Tamura and Satoshi Yamagiwa and Yohei Aoki and So Kurita and Takeshi Suda and Shogo Ohkoshi and Minoru Nomoto and Yutaka Aoyagi},
  journal={Digestive Diseases and Sciences},
  year={2008},
  volume={54},
  pages={2530-2537}
}
The association between serum alpha-fetoprotein (AFP) levels during and after interferon (IFN) therapy and the development of hepatocellular carcinoma (HCC) was evaluated in patients with chronic hepatitis C (CHC). A total of 263 patients treated by IFN with or without ribavirin were enrolled in the study. Serum AFP levels during and after IFN therapy were… CONTINUE READING